| Abstract: | An enzyme‐linked immunosorbent assay (ELISA) for the detection of Marek's disease virus (MDV)‐specific antibodies was developed. Chicken embryo cells (CEC) or chicken kidney cells (CKC) were infected with MDV vaccine strain CVI988/Rispens, and infected‐cell lysates were prepared at day 5 post‐infection by freeze‐thawing. Uninfected‐cell lysates served as negative controls. Sera were used at a 1 : 100 dilution and were added in parallel to wells containing the infected and uninfected cell lysates. The optical densities at 492 nm (OD492 nm) were measured after detection of bound chicken antibodies with anti‐chicken IgG peroxidase conjugate and colour reactions using o‐phenylenediamine (OPD) as a substrate. The best results concerning the signal‐to‐noise ratio were obtained by using CKC cells rather than CEC for antigen preparation. The OD492 nm of plasma or serum samples with infected CKC was <0.02 when samples of unvaccinated and unchallenged maternal antibody‐negative white leghorn chickens were tested. Sera and plasma samples of positive control birds exhibited OD492 nm of <0.01 when tested with uninfected CKC. The assay was used to monitor a trial that compared experimental BAC DNA vaccines and a commercial vaccine. Sustained seroconversion and antibody titers that were constantly rising until day 84 after vaccination (71 days after challenge) was observed only when chickens did not develop Marek's disease. In contrast, chickens developing the disease mounted marginal and short‐lived antibody titers only. We conclude that the developed ELISA may be a valuable tool for the evaluation of the efficacy of MDV vaccination under experimental but possibly also under field conditions. |
